Suppr超能文献

肾病综合征中的纤溶酶原激活物。

Plasminogen activator in nephrotic syndrome.

作者信息

Andreenko G V, Podoroldskaya L V, Polyantseva L P

机构信息

Laboratory of Enzymatic Fibrinolysis, School of Biology, Moscow State University, USSR.

出版信息

Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(3):351-5.

PMID:2465229
Abstract

Plasminogen activators were studied in blood urine in 207 patients with nephrotic syndrome of different etiological forms. The blood plasminogen activator activity was decreased in chronic glomerulonephritis, SLE, systemic vasculities as result of great level of inhibitors (L2M), penetration of enzymes to abdominal and pleural transudates, excretion to urine. The blood plasminogen activator activity and urokinase level in chronic glomerulonephritis was dependent on the degree of nephrotic syndrome. The plasminogen activator in amyloidosis was sharply elevated because of permanent irritability of endothelial wall by amyloid mass. Venous occlusion caused the release of plasminogen activator to blood only in more favourable clinical course of nephrotic syndrome.

摘要

对207例不同病因类型的肾病综合征患者的血尿中的纤溶酶原激活剂进行了研究。由于抑制剂(L2M)水平较高、酶渗透到腹腔和胸腔渗出液以及排泄到尿液中,慢性肾小球肾炎、系统性红斑狼疮、系统性血管炎患者的血液纤溶酶原激活剂活性降低。慢性肾小球肾炎患者的血液纤溶酶原激活剂活性和尿激酶水平取决于肾病综合征的程度。淀粉样变性患者的纤溶酶原激活剂因淀粉样物质对内皮壁的持续刺激而急剧升高。仅在肾病综合征更有利的临床病程中,静脉阻塞才会导致纤溶酶原激活剂释放到血液中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验